Federal Charges and Civil Action Announced in Efforts to Combat Opioid Epidemic
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Federal Charges and Civil Action Announced in Efforts to Combat Opioid Epidemic

Federal Charges and Civil Action Announced in Efforts to Combat Opioid Epidemic

October 01, 2019
|
Share Article
|
Download Press Release
For Immediate Release
Contact: SA Crystal Harper
Phone Number: (571) 362-3433

Charges announced as part of Georgia and Florida coordinated takedown

SAVANNAH, Ga:  Pharmacists, a pharmacy, and several individuals have been named as defendants in various criminal and civil actions filed in federal court in the Southern District of Georgia as part of continuing efforts by the U.S. Attorney’s Office to combat the opioid epidemic.

The actions in Georgia and Florida were coordinated by the U.S. Department of Justice, and include 67 individuals charged in connection with various healthcare and controlled substance schemes.

For the actions taken in the Southern District of Georgia, U.S. Attorney Bobby L. Christine announced the following actions:

  • A civil lawsuit in U.S. District Court in Brunswick, Ga., accuses Darien Pharmacy and Janice Ann Colter, 62, of Darien, Ga., pharmacist-in-charge of Darien Pharmacy, with filling prescriptions for controlled substances that she “knew or should have known were not issued for legitimate medical reasons and by a provider not acting with the regular course of professional practice.” The lawsuit represents the first-ever Controlled Substances Act suit against a pharmacy in the history of the Southern District of Georgia.
  • A federal grand jury in Savannah indicted Jenna Savage, 26, of Port Wentworth, Ga.; Norman Lee Burnsed, 27, of Port Wentworth, Ga.; Tucker Chambers, 21, of Ellabell, Ga.; Macaila Brown, 22, of Rincon, Ga.; and Cameron Hilliard, 26, of Savannah, Ga., with conspiracy charges under the Controlled Substances Act relating to the distribution of oxycodone, Adderall, alprazolam, and clonazepam. Savage was further charged with 50 counts of illegally acquiring a controlled substance.
  • A criminal information charges David L. Williford, 59, of Rincon, Ga., with illegally acquiring oxycodone. Williford, a pharmacist, is alleged in the information to have acquired the oxycodone from a pharmacy where he was employed.

Robert J. Murphy, the special agent in charge of the DEA Atlanta Division, said “Pharmaceutical products that are distributed for non-medical reasons can be just as deadly as illicit drugs. The defendants in these cases endangered the community by their actions. These cases have been a success because of the unified efforts of our federal, state and local law enforcement counterparts.”

“Nearly 70,000 people in the United States die each year from drug overdoses, and more than two-thirds of those deaths are due to opioid abuse,” said Bobby L. Christine, U.S. attorney for the Southern District of Georgia. “It is beyond outrageous when medical professionals and others fuel this crisis by pouring illegally prescribed drugs into the illicit drug supply pipeline, and our office will continue to take aim at such illegal activity.”

“Being a healthcare professional in the Medicare program is a privilege, not a right. When physicians and other healthcare providers put their own financial gain above patient well-being and honest billing of government health programs, they violate the basic trust that taxpayers extend to healthcare professionals,” said Special Agent in Charge Derrick L. Jackson of the HHS-OIG Atlanta Regional Office. “These cases put corrupt medical professionals on alert that law enforcement will do everything possible to root out all forms of waste, fraud and abuse in our federal health care programs.”

Criminal indictments and informations contain only charges; defendants are presumed innocent unless and until proven guilty. The claims asserted against defendants in a civil suit are allegations only and are not determinations of liability.

These cases are being investigated by the Drug Enforcement Administration and the Department of Health and Human Resources Office of Inspector General, and prosecuted for the United States by Assistant U.S. Attorneys Bradford Patrick, Jonathan Porter, Katelyn Semales, and Marcela C. Mateo.

The DEA encourages parents, along with their children, to educate themselves about the dangers of legal and illegal drugs by visiting DEA’s interactive websites at www.justhinktwice.com, www.GetSmartAboutDrugs.com and www.dea.gov. Also follow DEA Atlanta via Twitter at @DEAATLANTADiv.

 

###

Download Press Release
###
Oxycodone
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jae W. Chung, Acting Special Agent in Charge - Atlanta
@DEAAtlantaDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster